Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.
NCI Provides $40 Million To Four Centers For Cancer Communications Research.
Talpin To Join NCI
Pat Barr, Early NBCC Activist, Dead.
Cancer Groups Criticize Prescription Drug Bills.
AstraZeneca To Pay $335M In Illegal Pricing Penalties.
GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.
Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds









